CH3), 2.19 (m, 8H, hexyl-CH2), 1.75 (m, 8H, hexyl-CH2), 1.53
hexyl-CH2), 1.01 (m, 12H, hexyl-CH3). 31P{1H} NMR (101
t
t
(s, 9H, Bu–CH3), 1.51 (s, 9H, Bu–CH3), 1.47 (m, 8H, hexyl-
CH2), 1.39 (t, 6H, J ¼ 7 Hz, P–O–CH2–CH3), 1.27 (m, 8H,
hexyl-CH2), 0.92 (t, 12H, J ¼ 7 Hz, hexyl-CH3). 31P{1H}
NMR (101 MHz, CDCl3): d ¼ ꢀ5. LDI-TOF MS: m/z calcd
for C74H101N4O3PZn 1188.69, found 1189.16.
MHz, CDCl3): d ¼ ꢀ176 (1JPH ¼ 215 Hz). LDI-TOF MS:
m/z calcd for C70H93N4NiP 1078.65, found 1079.17.
NMR experiments
(PAPH2)2Ru-4. Ru-4 (50 mg, 50 mmol) was added to a solu-
tion of 60 mg (450 mmol) of PAPH2 in 100 ml dry THF and the
solution was stirred for 1 h at room temperature. The solvent
was evaporated and the dark red residue was dried in vacuo.
The solid was redissolved in 2.0 ml of C6D6 and directly used
for NMR measurements. 1H{31P} NMR (C6D6 , 500 MHz):
d ¼ 10.31 (s, 2H, meso-H), 8.20 (s, 4H, o-Ar–H), 7.99 (s, 2H,
p-Ar–H), 6.92–6.97 (m, 10H, Ar–H of PAPH2), 4.00 (m, 8H,
ethyl-CH2), 2.77 (s, 12H, b-pyrrole CH3), 1.83 (m, 12H,
hexyl-CH3), 1.48 (s, 36H, tBu–CH3), ꢀ0.6 (s, 4H, PH2).
31P{1H} NMR (C6D6 , 101 MHz): d ¼ ꢀ102 (s). Signals for
some mono-complex at d ꢀ 120 (bs) and free phosphine at
d ꢀ 178 ppm (bs) were detected as well. The [AX2]2 coupling
pattern was analysed initially using the [AXn]2 spin system,
para-Ni-1. Yield 58.7 mg (49.6 mmol; 52%) from 100 mg
acetylene nickel porphyrin (95.4 mmol). 1H NMR (CDCl3 ,
500 MHz): d ¼ 9.42 (s, 2H, meso-H), 7.83 (d, J ¼ 8 Hz, 2H,
Ar–H), 7.79 (d, J ¼ 8 Hz, 2H, Ar–H), 7.68 (d, J ¼ 2 Hz,
2H, Ar–H), 7.67 (t, J ¼ 2 Hz, 1H, Ar–H), 3.94 (p, 4H, J ¼ 7
Hz, P–O–CH2–CH3), 3.63 (t, J ¼ 8 Hz, 8H, hexyl-CH2), 2.25
(s, 6H, b-pyrrole CH3), 2.23 (s, 6H, b-pyrrole CH3), 2.20
(p, J ¼ 7 Hz, 8H, hexyl-CH2), 1.58 (p, J ¼ 7 Hz, 8H, hexyl-
CH2), 1.42 (s, 18H, tBu–CH3), 1.34 (m, 16H, hexyl-CH2),
1.28 (t, 6H, J ¼ 7 Hz, P–O–CH2–CH3), 0.88 (2 ꢄ t, J1 ¼ 2
Hz, J2 ¼ 7 Hz, 12H, hexyl-CH3). 31P{1H} NMR (101 MHz,
CDCl3): d ¼ ꢀ5. LDI-TOF MS: m/z calcd for
C74H101N4O3PNi 1182.70, found 1183.03.
4
which assumes that JHH ¼ 0 H. The approximate coupling
constants were then refined using WINDAISY.
Zn-2. meta-Zn-1 (50.0 mg, 42 mmol) was dissolved in 3.0 ml
of Et2O at 0 ꢁC (ice bath). After addition of 4.8 mg LiAlH4
(126 mmol) in one portion, the red solution was stirred at
0 ꢁC for 2 h. Then, the solution was transferred via canula into
a flask containing 50 ml CH2Cl2 and 30 ml brine and the mix-
ture was stirred vigorously for 10 min. The organic phase was
separated and concentrated in vacuo. The crude product was
dissolved in ca. 2 ml THF, transferred onto a silica column
via syringe and flash chromatographed using THF as eluent.
This yielded a total of 32.5 mg of porphyrinic product.
Ni-2/Zn-3 with Ru-4/Rh-5. Solutions of 5.0 mg of the phos-
phine porphyrins (500 ml C6D6) were titrated with 5.0 mM
solutions of the acceptor porphyrins (C6D6) in 10 to 50 ml
portions and the 1H NMR spectra were recorded after each
addition. The final spectrum was obtained when virtually all
uncomplexed phosphine was consumed.
1
Acknowledgements
According to the H NMR spectrum, the mixture contained
13.4 mg Zn-2 (12.3 mmol, 30%); Rf (hexane–ethyl acetate 5:1)
0.8. 1H NMR (CDCl3 , 500 MHz): d ¼ 10.55 (s, 2H, meso-
H), 8.44 (s, 2H, Ar–H), 8.25 (m, 2H, Ar–H), 8.14 (bs, 1H,
Ar–H), 8.01 (d, J ¼ 7 Hz, 1H, Ar–H), 7.59 (d, J ¼ 7 Hz,
1H, Ar–H), 7.11 (m, 1H, alkene-H), 6.50 (m, 1H, alkene-H),
We thank Prof. J.-C. Guillemin (ENSC Rennes, France) for
many helpful comments on the synthesis of PAPH2 . Financial
support from the Swiss National Science Foundation (E.S.)
and from the EPSRC is gratefully acknowledged.
1
3
4.12 (m, 8H, hexyl-CH2), 3.54 (dd, JPH ¼ 200 Hz, JHH ¼ 5
Hz, 2H, PH2), 2.79 (s, 6H, b-pyrrole CH3), 2.71 (s, 6H, b-pyr-
role CH3), 2.44 (m, 8H, hexyl-CH2), 1.89 (m, 8H, hexyl-CH2),
1.59 (s, 18H, tBu–CH3), 1.58 (m, 8H, hexyl-CH2), 1.46 (m, 8H,
hexyl-CH2), 1.02 (m, 12H, hexyl-CH3). 31P{1H} NMR (101
References
1
2
S. L. Darling, E. Stulz, N. Feeder, N. Bampos and J. K. M.
Sanders, New J. Chem., 2000, 24, 261–264.
2
MHz, CDCl3): d ¼ ꢀ136 (1JPH ¼ 200 Hz, JPH ¼ 12 Hz).
(a) E. Stulz, Y.-F. Ng, S. M. Scott and J. K. M. Sanders, Chem.
Commun., 2002, 524–525; (b) E. Stulz, S. M. Scott, A. D. Bond,
S. J. Teat and J. K. M. Sanders, Chem.-Eur. J., 2003, 9, 6039–
6048; (c) E. Stulz, S. M. Scott, Y.-F. Ng, A. D. Bond, S. J. Teat,
S. L. Darling, N. Feeder and J. K. M. Sanders, Inorg. Chem.,
2003, 42, 6564–6574.
LDI-TOF MS: m/z calcd for C70H93N4PZn 1084.64, found
1084.57.
Ni-3. To a suspension of 8.0 mg (210 mmol) LiAlH4 in 15 ml
dry THF were added 42 mg (315 mmol) AlCl3 at ꢀ78 ꢁC. The
suspension was allowed to warm to 0 ꢁC and cooled again to
ꢀ78 ꢁC. To the grey slurry mixture, a solution of 96.7 mg
Ni-2 in 5 ml dry THF was added slowly over a period of 30
min. After the reduction was complete (TLC check, hexane–
ethyl acetate 5:1), the suspension was allowed to warm to
0 ꢁC. The mixture was filtered through a canula fitted with a
filter paper and transferred into a flask containing 20 mg
sodium bicarbonate and 40 mg sodium sulfate at 0 ꢁC. After
vigorous stirring for 5 min, the solution was filtered as before
and the residue was washed with dry THF until colourless.
After evaporating the solvents, the red residue was flash chro-
matographed on silica (THF) yielding 53 mg of porphyrinic
product. According to the 1H NMR spectrum, the mixture
contained 36.5 mg Ni-3 (33.3 mmol, 41%); Rf (hexane–ethyl
acetate 5:1) 0.9. 1H NMR (CDCl3 , 500 MHz): d ¼ 9.86 (s,
2H, meso-H), 7.90 (s, 1H, Ar–H), 7.85 (s, 2H, Ar–H), 7.61
(d, J ¼ 8 Hz, 2H, Ar–H), 7.53 (d, J ¼ 8 Hz, 2H, Ar–H),
3
(a) S. Ariel, D. Dolphin, G. Domazetis, B. R. James, T. W. Leung,
S. J. Rettig, J. Trotter and G. M. Williams, Can. J. Chem., 1984,
62, 755–762; (b) M. Barley, J. Y. Becker, G. Domazetis, D.
Dolphin and B. R. James, Can. J. Chem., 1983, 61, 2389–2396;
(c) V. Grass, D. Lexa, M. Momenteau and J. M. Saveant,
J. Am. Chem. Soc., 1997, 119, 3536–3542; (d ) B. R. James, D.
Dolphin, T. W. Leung, F. W. B. Einstein and A. C. Willis, Can.
J. Chem., 1984, 62, 1238–1245; (e) K. M. Kadish, C. Araullo
and C.-L. Yao, Organometallics, 1988, 7, 1583–1587; ( f ) K. M.
Kadish, Y. Hu, P. Tagliatesta and T. Boschi, J. Chem. Soc.,
Dalton Trans., 1993, 1167–1172; (g) C. D. Tait, D. Holten,
M. H. Barley, D. Dolphin and B. R. James, J. Am. Chem. Soc.,
1985, 107, 1930–1934; (h) B. B. Wayland, A. E. Sherry and
A. G. Bunn, J. Am. Chem. Soc., 1993, 115, 7675–7684.
4
(a) R. J. Cheng, S. H. Lin and H. M. Mo, Organometallics,
1997, 16, 2121–2126; (b) M. Guillemot and G. Simonneaux,
J. Chem. Soc., Chem. Commun., 1995, 2093–2094; (c) T. Ohya,
H. Morohoshi and M. Sato, Inorg. Chem., 1984, 23, 1303–1305;
(d ) T. Ohya, H. Morohoshi and M. Sato, J. Pharmacobio. Dyn.,
1985, 8, S14–S14; (e) G. Simonneaux and P. Sodano, Inorg.
Chem., 1988, 27, 3956–3959; ( f ) G. Simonneaux and P. Le Maux,
Coord. Chem. Rev., 2002, 228, 43–60.
1
3.83 (m, 8H, hexyl-CH2), 3.78 (d, 2H, JPH ¼ 214 Hz, PH2),
2.56 (s, 6H, b-pyrrole CH3), 2.43 (s, 6H, b-pyrrole CH3),
2.21 (m, 8H, hexyl-CH2), 1.73 (m, 8H, hexyl-CH2), 1.50 (s,
18H, tBu–CH3), 1.49 (m, 8H, hexyl-CH2), 1.44 (m, 8H,
5
(a) G. W. Rabe, H. Heise, L. M. Liable-Sands, I. A. Guzei and
A. L. Rheingold, J. Chem. Soc., Dalton Trans., 2000, 1863–1866;
(b) E. Urnezius, S. J. Klippenstein and J. D. Protasiewicz, Inorg.
T h i s j o u r n a l i s Q T h e R o y a l S o c i e t y o f C h e m i s t r y a n d t h e
C e n t r e N a t i o n a l d e l a R e c h e r c h e S c i e n t i f i q u e 2 0 0 4
N e w . J . C h e m . , 2 0 0 4 , 2 8 , 1 0 6 6 – 1 0 7 2
1071